Cost-minimisation analysis of pegylated liposomal doxorubicin hydrochloride versus topotecan in the treatment of patients with recurrent epithelial ovarian cancer in Spain

  1. Ojeda, B.
  2. De Sande, L.M.
  3. Casado, A.
  4. Merino, P.
  5. Casado, Ma.
Journal:
British Journal of Cancer

ISSN: 0007-0920

Year of publication: 2003

Volume: 89

Issue: 6

Pages: 1002-1007

Type: Article

DOI: 10.1038/SJ.BJC.6601228 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus